Search Results - "Chaisson RE"

The persistence of tuberculosis in the age of DOTS: reassessing the effect of case detection.

Authors: Dowdy DW Chaisson RE

Source: Bulletin of the World Health Organization. Apr2009, Vol. 87 Issue 4, p296-304. 9p.

URL: 37574203

Time of exposure and risk of HIV infection in homosexual partners of men with AIDS.

Authors: Osmond D Bacchetti P Chaisson RE et al.

Source: American Journal of Public Health. Aug1988, Vol. 78 Issue 8, p944-948. 5p.

Subjects: HIV infections, Gay people, AIDS, Anal sex, Sexual intercourse, Sexually transmitted diseases, Communicable diseases, HIV, Public health

Safety and tolerability of intermittent rifampin/pyrazinamide for the treatment of latent tuberculosis infection in prisoners.

Authors: Chaisson RE Armstrong J Stafford J et al.

Source: JAMA: Journal of the American Medical Association. 7/10/2002, Vol. 288 Issue 2, p165-166. 2p.

Duration of the survival benefit of zidovudine therapy in HIV infection.

Authors: Moore RD Keruly JC Chaisson RE

Source: Archives of Internal Medicine. 5/27/96, Vol. 156 Issue 10, p1073-1077. 5p.

Three months of rifapentine and isoniazid for latent tuberculosis infection.

Authors: Sterling TR Villarino ME Borisov AS et al.

Source: New England Journal of Medicine. 12/8/2011, Vol. 365 Issue 23, p2155-2166. 12p.

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.

Authors: Nachega JB Hislop M Dowdy DW et al.

Source: Annals of Internal Medicine. 4/17/2007, Vol. 146 Issue 8, p564-28. 10p.

URL: 24806032

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.

Authors: Umbricht A Hoover DR Tucker MJ et al.

Source: Drug & Alcohol Dependence. Apr2003, Vol. 69 Issue 3, p263-272. 10p.

Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure.

Authors: Kimura M Converse PJ Astemborski J et al.

Source: Journal of Infectious Diseases. 5/1/99, Vol. 179 Issue 5, p1297-1300. 4p.

Racial differences in the use of drug therapy for HIV disease in an urban community.

Authors: Moore RD Stanton D Gopalan R et al.

Source: New England Journal of Medicine. 3/17/94, Vol. 330 Issue 11, p763-768. 6p.

Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

Authors: Nightingale SD Cameron DW Gordin FM et al.

Source: New England Journal of Medicine. 9/16/93, Vol. 329 Issue 12, p828-833. 6p.

Reconsidering global targets for tuberculosis control.

Authors: Marais BJ van Helden PD Dowdy DW et al.

Source: Bulletin of the World Health Organization. Dec2009, Vol. 87 Issue 12, pA-C. 1p.

URL: 47174085

Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial.

Authors: Durovni B Cordeiro-Santos M Cavalcante SC et al.

Corporate Authors: Durovni B Cordeiro-Santos M Cavalcante SC et al.

Source: PLoS medicine [PLoS Med] 2026 Feb 10; Vol. 23 (2), pp. e1004758. Date of Electronic Publication: 2026 Feb 10 (Print Publication: 2026).

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase IV; Multicenter Study; Comparative Study

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE

Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020.

Authors: Kurbatova EV Whitworth WC Bryant KE et al.

Corporate Authors: Kurbatova EV Whitworth WC Bryant KE et al.

Source: Emerging infectious diseases [Emerg Infect Dis] 2025 Dec; Vol. 31 (12), pp. 2233-2242.

Publication Type: Journal Article; Clinical Trial, Phase III

Journal Info: Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE

Treatment completion and challenges in rolling out 12-dose weekly rifapentine plus isoniazid to prevent tuberculosis among people living with HIV and pediatric household contacts in Brazil.

Authors: Salles I Oliveira JG Souza AB et al.

Source: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia [J Bras Pneumol] 2025 Oct 27; Vol. 51 (4), pp. e20250125. Date of Electronic Publication: 2025 Oct 27 (Print Publication: 2025).

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Sociedade Brasileira de Pneumologia e Tisilogia Country of Publication: Brazil NLM ID: 101222274 Publication Model: eCollection Cited Medium: Internet ISSN: 1806-3756 (Electronic) Linking ISSN: 18063713 NLM ISO Abbreviation: J Bras Pneumol Subsets: MEDLINE

Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial.

Authors: Chihota V Waggie Z Cardenas V et al.

Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2026 May 17. Date of Electronic Publication: 2026 May 17.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Stakeholder engagement to identify barriers to implementation and inform the development of point-of-care diagnostics for TB.

Authors: Salles I Lessem E Walshe L et al.

Source: IJTLD open [IJTLD Open] 2026 Apr 13; Vol. 3 (4), pp. 255-261. Date of Electronic Publication: 2026 Apr 13 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: International Union against Tuberculosis and Lung Disease Country of Publication: France NLM ID: 9918803487706676 Publication Model: eCollection Cited Medium: Internet ISSN: 3005-7590 (Electronic) Linking ISSN: 30057590 NLM ISO Abbreviation: IJTLD Open Subsets: PubMed not MEDLINE

The looming crisis of bedaquiline-resistant tuberculosis and a promising way forward.

Authors: Howell P Stillo J Reuter A et al.

Source: The Lancet. Infectious diseases [Lancet Infect Dis] 2026 Feb 16. Date of Electronic Publication: 2026 Feb 16.

Publication Type: Journal Article; Review

Journal Info: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

Comprehensive tuberculosis screening and preventive treatment in schools and congregate settings of India (2017-2024): a prospective study.

Authors: Dorjee K Topgyal S Sood RK et al.

Source: The Lancet regional health. Southeast Asia [Lancet Reg Health Southeast Asia] 2026 Feb 06; Vol. 46, pp. 100725. Date of Electronic Publication: 2026 Feb 06 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9918419282806676 Publication Model: eCollection Cited Medium: Internet ISSN: 2772-3682 (Electronic) Linking ISSN: 27723682 NLM ISO Abbreviation: Lancet Reg Health Southeast Asia Subsets: PubMed not MEDLINE

Preventing Multidrug-Resistant Tuberculosis: The Dawn of a New Era.

Authors: Churchyard GJ Swindells S Gupta A et al.

Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2026 Feb 04; Vol. 81 (6), pp. 1135-1140.

Publication Type: Journal Article; Review

Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes.

Authors: Kurbatova EV Whitworth WC Peddareddy LP et al.

Corporate Authors: Kurbatova EV Whitworth WC Peddareddy LP et al.

Source: Emerging infectious diseases [Emerg Infect Dis] 2025 Mar; Vol. 31 (3), pp. 467-476.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155 Publication Model: Print Cited Medium: Internet ISSN: 1080-6059 (Electronic) Linking ISSN: 10806040 NLM ISO Abbreviation: Emerg Infect Dis Subsets: MEDLINE